TY - JOUR
T1 - Inflammation dynamics of atopic dermatitis
T2 - Phase transition and scaling law of remission time
AU - Kang, Yoseb
AU - Hwang, Jaewoo
AU - Jang, Yong Hyun
AU - Lai, Ying Cheng
AU - Do, Younghae
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/8
Y1 - 2025/8
N2 - Atopic dermatitis (AD) is a prevalent skin disorder affecting individuals globally, with many patients experiencing a range of symptoms. A pronounced clinical phenomenon associated with AD is the cyclic alternation of two distinct phases in time: inflammation and remission, depending on patients’ immune response and skin permeability. Frequent and relatively long inflammatory times lead to symptoms that can severely deteriorate the quality of life for the patient. Through mathematical modeling, we find that patients with similar AD symptoms can be categorized into two phases depending on the skin permeability and immune response that constitute the most clinically relevant parameter plane: the inflammatory time is shorter or longer than the remission time, respectively and the transition between the two phases is of the second-order type. In the parameter plane, a critical threshold curve emerges, which separates the two phases. Computing the frequency and duration of the inflammatory response, we uncover a logarithmic scaling law governing the inflammatory and remission times and discuss its clinical implications. In particular, when the skin condition is managed to be near the phase transition point, the benefits of treatment are more pronounced. However, at this stage, the effectiveness of skincare in reducing flare-ups tends to be less noticeable, making it difficult to evaluate the success of the treatment, largely due to the nature of logarithmic decay in the remission time. Our study provides insights into the mechanisms of AD that can enhance diagnostic accuracy and treatment by understanding the alternation between inflammation and remission periods.
AB - Atopic dermatitis (AD) is a prevalent skin disorder affecting individuals globally, with many patients experiencing a range of symptoms. A pronounced clinical phenomenon associated with AD is the cyclic alternation of two distinct phases in time: inflammation and remission, depending on patients’ immune response and skin permeability. Frequent and relatively long inflammatory times lead to symptoms that can severely deteriorate the quality of life for the patient. Through mathematical modeling, we find that patients with similar AD symptoms can be categorized into two phases depending on the skin permeability and immune response that constitute the most clinically relevant parameter plane: the inflammatory time is shorter or longer than the remission time, respectively and the transition between the two phases is of the second-order type. In the parameter plane, a critical threshold curve emerges, which separates the two phases. Computing the frequency and duration of the inflammatory response, we uncover a logarithmic scaling law governing the inflammatory and remission times and discuss its clinical implications. In particular, when the skin condition is managed to be near the phase transition point, the benefits of treatment are more pronounced. However, at this stage, the effectiveness of skincare in reducing flare-ups tends to be less noticeable, making it difficult to evaluate the success of the treatment, largely due to the nature of logarithmic decay in the remission time. Our study provides insights into the mechanisms of AD that can enhance diagnostic accuracy and treatment by understanding the alternation between inflammation and remission periods.
KW - Atopic dermatitis
KW - Logarithm scaling law
KW - Phase transition
UR - https://www.scopus.com/pages/publications/105006881378
U2 - 10.1016/j.compbiomed.2025.110391
DO - 10.1016/j.compbiomed.2025.110391
M3 - Article
C2 - 40460568
AN - SCOPUS:105006881378
SN - 0010-4825
VL - 194
JO - Computers in Biology and Medicine
JF - Computers in Biology and Medicine
M1 - 110391
ER -